Rite Aid Corporation (NYSE: RAD) Stock Competitors & Peer Comparison
See RAD's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RAD and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RAD | $0.65 | -16.81% | 36.8M | -0.05 | -$14.34 | N/A |
| RPRX | $67.18 | +1.90% | 29.9B | 12.80 | $5.25 | +1.38% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| CORT | $81.12 | -5.62% | 8.8B | 231.69 | $0.35 | N/A |
| KNSA | $92.24 | -5.45% | 7.2B | 70.96 | $1.30 | N/A |
| LQDA | $45.06 | +0.16% | 4B | 32.91 | $1.37 | N/A |
| PBH | $49.06 | +0.64% | 2.3B | 11.10 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $13.95 | -10.23% | 836.1M | -5.52 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
RAD vs RPRX Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, RPRX has a market cap of 29.9B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while RPRX trades at $67.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas RPRX's P/E ratio is 12.80. In terms of profitability, RAD's ROE is +2.76%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, RAD is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check RPRX's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
RAD vs WBA Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas WBA's P/E ratio is -1.64. In terms of profitability, RAD's ROE is +2.76%, compared to WBA's ROE of -0.57%. Regarding short-term risk, RAD is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check WBA's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
RAD vs CORT Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CORT has a market cap of 8.8B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CORT trades at $81.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CORT's P/E ratio is 231.69. In terms of profitability, RAD's ROE is +2.76%, compared to CORT's ROE of +0.08%. Regarding short-term risk, RAD is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CORT's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
RAD vs KNSA Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, KNSA has a market cap of 7.2B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while KNSA trades at $92.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas KNSA's P/E ratio is 70.96. In terms of profitability, RAD's ROE is +2.76%, compared to KNSA's ROE of +0.17%. Regarding short-term risk, RAD is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
RAD vs LQDA Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, LQDA has a market cap of 4B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LQDA trades at $45.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas LQDA's P/E ratio is 32.91. In terms of profitability, RAD's ROE is +2.76%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, RAD is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
RAD vs PBH Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, PBH has a market cap of 2.3B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while PBH trades at $49.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas PBH's P/E ratio is 11.10. In terms of profitability, RAD's ROE is +2.76%, compared to PBH's ROE of +0.09%. Regarding short-term risk, RAD is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for RAD.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
RAD vs HROWL Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas HROWL's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, RAD is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
RAD vs HROWM Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas HROWM's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, RAD is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
RAD vs LTGO Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, LTGO has a market cap of 836.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LTGO trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas LTGO's P/E ratio is -5.52. In terms of profitability, RAD's ROE is +2.76%, compared to LTGO's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
RAD vs HELP Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, HELP has a market cap of 656.7M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HELP trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas HELP's P/E ratio is -2.54. In terms of profitability, RAD's ROE is +2.76%, compared to HELP's ROE of -0.71%. Regarding short-term risk, RAD is more volatile compared to HELP. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
RAD vs SVA Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SVA's P/E ratio is -5.68. In terms of profitability, RAD's ROE is +2.76%, compared to SVA's ROE of -0.01%. Regarding short-term risk, RAD is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
RAD vs CUVL Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CUVL has a market cap of 252.4M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CUVL trades at $5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CUVL's P/E ratio is 10.79. In terms of profitability, RAD's ROE is +2.76%, compared to CUVL's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
RAD vs HITI Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, HITI has a market cap of 229.5M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while HITI trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas HITI's P/E ratio is -9.51. In terms of profitability, RAD's ROE is +2.76%, compared to HITI's ROE of -0.36%. Regarding short-term risk, RAD is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for RAD.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
RAD vs CELG-RI Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CELG-RI has a market cap of 198.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CELG-RI trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, RAD is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CELG-RI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
RAD vs ETRA Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ETRA has a market cap of 170.8M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ETRA trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ETRA's P/E ratio is -3.04. In terms of profitability, RAD's ROE is +2.76%, compared to ETRA's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to ETRA. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
RAD vs TRXB Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, TRXB has a market cap of 112.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while TRXB trades at $13.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas TRXB's P/E ratio is -5.47. In terms of profitability, RAD's ROE is +2.76%, compared to TRXB's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to TRXB. This indicates higher risk in terms of short-term price fluctuations for RAD.Check TRXB's competition here
Atlantic International Corp. (NASDAQ: ATLN)
RAD vs ATLN Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ATLN's P/E ratio is -0.68. In terms of profitability, RAD's ROE is +2.76%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, RAD is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for RAD.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
RAD vs CTOR Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CTOR has a market cap of 52.4M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CTOR trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CTOR's P/E ratio is -1.20. In terms of profitability, RAD's ROE is +2.76%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, RAD is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CTOR's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
RAD vs RTSN Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, RTSN has a market cap of 43.8M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while RTSN trades at $11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas RTSN's P/E ratio is -4.47. In terms of profitability, RAD's ROE is +2.76%, compared to RTSN's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to RTSN. This indicates higher risk in terms of short-term price fluctuations for RAD.Check RTSN's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
RAD vs GLTO Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas GLTO's P/E ratio is -1.78. In terms of profitability, RAD's ROE is +2.76%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, RAD is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for RAD.Check GLTO's competition here
Cosmos Health Inc. (NASDAQ: COSM)
RAD vs COSM Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while COSM trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas COSM's P/E ratio is -0.42. In terms of profitability, RAD's ROE is +2.76%, compared to COSM's ROE of -1.19%. Regarding short-term risk, RAD is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for RAD.Check COSM's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
RAD vs NSRX Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, NSRX has a market cap of 27.2M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while NSRX trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas NSRX's P/E ratio is -4.39. In terms of profitability, RAD's ROE is +2.76%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, RAD is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
RAD vs SCYX Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SCYX has a market cap of 23.7M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SCYX trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SCYX's P/E ratio is -1.10. In terms of profitability, RAD's ROE is +2.76%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, RAD is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SCYX's competition here
Pomdoctor Limited (NASDAQ: POM)
RAD vs POM Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, POM has a market cap of 13.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while POM trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas POM's P/E ratio is -0.22. In terms of profitability, RAD's ROE is +2.76%, compared to POM's ROE of +0.80%. Regarding short-term risk, RAD is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for RAD.Check POM's competition here
Biofrontera Inc. (NASDAQ: BFRI)
RAD vs BFRI Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BFRI trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas BFRI's P/E ratio is -1.59. In terms of profitability, RAD's ROE is +2.76%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, RAD is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
RAD vs CNSY Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CNSY has a market cap of 12.8M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CNSY trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CNSY's P/E ratio is -0.40. In terms of profitability, RAD's ROE is +2.76%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, RAD is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CNSY's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
RAD vs CJJD Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CJJD's P/E ratio is -0.46. In terms of profitability, RAD's ROE is +2.76%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, RAD is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
RAD vs SSY Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SSY's P/E ratio is -2.86. In terms of profitability, RAD's ROE is +2.76%, compared to SSY's ROE of -0.09%. Regarding short-term risk, RAD is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for RAD.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
RAD vs SCNX Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SCNX trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SCNX's P/E ratio is -1.55. In terms of profitability, RAD's ROE is +2.76%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, RAD is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
RAD vs BGMS Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas BGMS's P/E ratio is -0.25. In terms of profitability, RAD's ROE is +2.76%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, RAD is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BGMS's competition here
Eocene Ltd. (NASDAQ: EOCN)
RAD vs EOCN Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, EOCN has a market cap of 3.1M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while EOCN trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas EOCN's P/E ratio is -0.22. In terms of profitability, RAD's ROE is +2.76%, compared to EOCN's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to EOCN. This indicates higher risk in terms of short-term price fluctuations for RAD.Check EOCN's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
RAD vs MDVL Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas MDVL's P/E ratio is -0.05. In terms of profitability, RAD's ROE is +2.76%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, RAD is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for RAD.Check MDVL's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
RAD vs PAVS Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, PAVS has a market cap of 2.8M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while PAVS trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas PAVS's P/E ratio is -0.04. In terms of profitability, RAD's ROE is +2.76%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, RAD is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for RAD.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
RAD vs ATNFW Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ATNFW's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, RAD is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
RAD vs BGMSP Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, RAD's ROE is +2.76%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, RAD is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
RAD vs AZNH Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas AZNH's P/E ratio is 38.35. In terms of profitability, RAD's ROE is +2.76%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, RAD is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for RAD.Check AZNH's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP)
RAD vs ASBP Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ASBP has a market cap of 944.9K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ASBP trades at $8.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ASBP's P/E ratio is -0.34. In terms of profitability, RAD's ROE is +2.76%, compared to ASBP's ROE of +19.93%. Regarding short-term risk, RAD is more volatile compared to ASBP. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ASBP's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
RAD vs BFRIW Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while BFRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas BFRIW's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, RAD is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check BFRIW's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
RAD vs LFLYW Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, RAD's ROE is +2.76%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, RAD is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check LFLYW's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBPW)
RAD vs ASBPW Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ASBPW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ASBPW's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, RAD is more volatile compared to ASBPW. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ASBPW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
RAD vs PRPH Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, PRPH has a market cap of 107.9K. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas PRPH's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, RAD is more volatile compared to PRPH. This indicates higher risk in terms of short-term price fluctuations for RAD.Check PRPH's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
RAD vs OREX Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, OREX has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas OREX's P/E ratio is -0.14. In terms of profitability, RAD's ROE is +2.76%, compared to OREX's ROE of -0.54%. Regarding short-term risk, RAD is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for RAD.Check OREX's competition here
Shire plc (NASDAQ: SHPG)
RAD vs SHPG Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas SHPG's P/E ratio is 11.35. In terms of profitability, RAD's ROE is +2.76%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, RAD is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for RAD.Check SHPG's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
RAD vs CPD Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, CPD has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas CPD's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to CPD's ROE of N/A. Regarding short-term risk, RAD is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for RAD.Check CPD's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
RAD vs ESRX Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas ESRX's P/E ratio is 10.69. In terms of profitability, RAD's ROE is +2.76%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, RAD is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for RAD.Check ESRX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
RAD vs IPXL Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas IPXL's P/E ratio is -10.11. In terms of profitability, RAD's ROE is +2.76%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, RAD is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for RAD.Check IPXL's competition here
POZEN Inc. (NASDAQ: POZN)
RAD vs POZN Comparison November 2026
Rite Aid Corporation (NYSE: RAD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAD stands at 36.8M. In comparison, POZN has a market cap of 0. Regarding current trading prices, RAD is priced at $0.65 on the NYSE, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAD currently has a P/E ratio of -0.05, whereas POZN's P/E ratio is N/A. In terms of profitability, RAD's ROE is +2.76%, compared to POZN's ROE of +0.61%. Regarding short-term risk, RAD is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for RAD.Check POZN's competition here